Cushman, W. C.

Journal Article

Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial.

Journal of the American Heart Association. 2018

Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome.

Clinical Cardiology. 2018

Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial.

JAMA internal medicine. 2017

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial.

Diabetes, Obesity & Metabolism. 2017

Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin.

Hypertension (Dallas, Tex.. 2016

Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial.

Diabetes care. 2016

Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance.

Hypertension (Dallas, Tex.. 2016

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Diabetes care. 2014

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

New England Journal of Medicine. 2013

Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Hypertension (Dallas, Tex.. 2013

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Kidney International. 2012

Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.

Circulation: Cardiovascular Quality and Outcomes. 2012

EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.

American Heart Journal. 2011

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

New England Journal of Medicine. 2011

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Lancet (London, England). 2010

Effects of combination lipid therapy in type 2 diabetes mellitus.

New England Journal of Medicine. 2010

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

New England Journal of Medicine. 2010

Effects of medical therapies on retinopathy progression in type 2 diabetes.

New England Journal of Medicine. 2010

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Archives of Internal Medicine. 2009

Effects of intensive glucose lowering in type 2 diabetes.

New England Journal of Medicine. 2008

Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Hypertension (Dallas, Tex.. 2007

Conference Paper

Microvascular effects of intensive blood pressure control and its relation to glycemic control in the ACCORD blood pressure trial

2011

Review

Blood pressure assessment in adults in clinical practice and clinic-based research: JACC Scientific Expert Panel [review].

Journal of the American College of Cardiology. 2019

Research needs to improve hypertension treatment and control in African Americans [review].

Hypertension (Dallas, Tex.. 2016

Abstract

Mortality findings from the EXAMINE Trial [abstract].

Diabetes. 2016

Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract].

Diabetes. 2015

Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract].

Diabetologia. 2011